MedTrace Logo

Sensory Attention Focused Exercise in Parkinson's Disease

NCT01246700 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2010-11-23

No results posted yet for this study

Summary

The purpose of this study is 1.) to determine if sensory attention focused exercise is an effective management strategy for Parkinson's disease, and 2.) to identify if the benefits are a result of strength gains.

Conditions

Interventions

OTHER

Sensory Attention Focused Exercise (SAFEx)

Consisted of 12 weeks for SAFEx intervention, 3 times a week for an hour each session. Participants complete dynamic balance activities and a variety of seated stretches and range of motion activities. Participants are cued to focus on sensation and proprioception of limbs. Group A received SAFEx for 12 weeks then received no treatment for 12 weeks.

OTHER

Sensory Attention Focused Exercise (SAFEx)

Consisted of 12 weeks for SAFEx intervention, 3 times a week for an hour each session. Participants complete dynamic balance activities and a variety of seated stretches and range of motion activities. Participants are cued to focus on sensation and proprioception of limbs. Group B received no treatment for 12 weeks, then received SAFEx for 12 weeks.

Sponsors & Collaborators

  • Canada, Young Men's Christian Association (YMCA)

    collaborator UNKNOWN

  • Parkinson Society Canada

    collaborator OTHER

  • Canada, Sun Life Financial

    collaborator UNKNOWN

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Sun Life Financial Movement Disorders Research and Rehabilitation Centre

    lead OTHER

Principal Investigators

  • Quincy J Almeida, Ph.D · Sun Life Financial Movement Disorders Research and Rehabilitation Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-12-31
Completion
2010-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01246700 on ClinicalTrials.gov